Trial Profile
Phase II trial of oral azacitidine (CC 486) in patients with solid tumours.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 May 2012
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 02 May 2012 New trial record